{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T18:27:31Z","timestamp":1770748051224,"version":"3.49.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T00:00:00Z","timestamp":1567641600000},"content-version":"am","delay-in-days":308,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["AA016834"],"award-info":[{"award-number":["AA016834"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA007238"],"award-info":[{"award-number":["DA007238"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.jsat.2018.08.015","type":"journal-article","created":{"date-parts":[[2018,9,2]],"date-time":"2018-09-02T01:17:48Z","timestamp":1535851068000},"page":"91-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Tobacco use during a clinical trial of mecamylamine for alcohol dependence: Medication effects on smoking and associations with reductions in drinking"],"prefix":"10.1016","volume":"94","author":[{"given":"Walter","family":"Roberts","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Ralevski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terril L.","family":"Verplaetse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherry A.","family":"McKee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ismene L.","family":"Petrakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jsat.2018.08.015_bb0005","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jsat.2008.06.003","article-title":"Smoking cessation during substance abuse treatment: What you need to know","volume":"36","author":"Baca","year":"2009","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2018.08.015_bb0010","doi-asserted-by":"crossref","first-page":"S555","DOI":"10.1080\/14622200701673480","article-title":"Time to first cigarette in the morning as an index of ability to quit smoking: Implications for nicotine dependence","volume":"9","author":"Baker","year":"2007","journal-title":"Nicotine & Tobacco Research"},{"issue":"5","key":"10.1016\/j.jsat.2018.08.015_bb0015","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/ntr\/ntp030","article-title":"The Wisconsin predicting patients' relapse questionnaire","volume":"11","author":"Bolt","year":"2009","journal-title":"Nicotine & Tobacco Research"},{"issue":"5","key":"10.1016\/j.jsat.2018.08.015_bb0020","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1360-0443.1998.9357137.x","article-title":"Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram","volume":"93","author":"Carroll","year":"1998","journal-title":"Addiction"},{"issue":"7","key":"10.1016\/j.jsat.2018.08.015_bb0025","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1046\/j.1360-0443.2003.00337.x","article-title":"Effects of nicotine deprivation on urges to drink and smoke in alcoholic smokers","volume":"98","author":"Cooney","year":"2003","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2018.08.015_bb0030","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1037\/0022-006X.58.3.310","article-title":"Intrinsic and extrinsic motivation for smoking cessation","volume":"58","author":"Curry","year":"1990","journal-title":"Journal of Consulting and Clinical Psychology"},{"issue":"11","key":"10.1016\/j.jsat.2018.08.015_bb0035","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1038\/nn1580","article-title":"Nicotine addiction and comorbidity with alcohol abuse and mental illness","volume":"8","author":"Dani","year":"2005","journal-title":"Nature Neuroscience"},{"key":"10.1016\/j.jsat.2018.08.015_bb0040","author":"European Medicines Agency"},{"issue":"12","key":"10.1016\/j.jsat.2018.08.015_bb0045","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/ntr\/nts018","article-title":"The Fagerstr\u00f6m test for nicotine dependence as a predictor of smoking abstinence: A pooled analysis of varenicline clinical trial data","volume":"14","author":"Fagerstr\u00f6m","year":"2012","journal-title":"Nicotine & Tobacco Research"},{"issue":"4","key":"10.1016\/j.jsat.2018.08.015_bb0050","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/ADM.0000000000000133","article-title":"Moderators of varenicline treatment effects in a double-blind, placebo-controlled trial for alcohol dependence: An exploratory analysis","volume":"9","author":"Falk","year":"2015","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.jsat.2018.08.015_bb0055","series-title":"Structured clinical interview for DSM-IV axis I disorders","author":"First","year":"1995"},{"issue":"2\u20133","key":"10.1016\/j.jsat.2018.08.015_bb0060","first-page":"229","article-title":"Nicotine dependence as a moderator of a quitline-based message framing intervention","volume":"114","author":"Fucito","year":"2011","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1016\/j.jsat.2018.08.015_bb0065","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s12160-010-9187-3","article-title":"Nicotine dependence as a moderator of message framing effects on smoking cessation outcomes","volume":"39","author":"Fucito","year":"2010","journal-title":"Annals of Behavioral Medicine"},{"issue":"5","key":"10.1016\/j.jsat.2018.08.015_bb0070","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/j.1360-0443.2007.01763.x","article-title":"A randomized, controlled trial to assess the efficacy and safety of a transdermal delivery system of nicotine\/mecamylamine in cigarette smokers","volume":"102","author":"Glover","year":"2007","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2018.08.015_bb0075","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.296.1.47","article-title":"Varenicline, an alpha-4 beta-2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: A randomized controlled trial","volume":"296","author":"Gonzales","year":"2006","journal-title":"JAMA: The Journal of the American Medical Association"},{"issue":"8","key":"10.1016\/j.jsat.2018.08.015_bb0080","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1001\/jamapsychiatry.2015.0584","article-title":"Epidemiology of DSM-5 alcohol use disorder: Results from the national epidemiologic survey on alcohol and related conditions III","volume":"72","author":"Grant","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"10.1016\/j.jsat.2018.08.015_bb0085","doi-asserted-by":"crossref","first-page":"202","DOI":"10.15288\/jsa.1995.56.202","article-title":"Interrelationship of smoking and alcohol dependence, use and urges to use","volume":"56","author":"Gulliver","year":"1995","journal-title":"Journal of Studies on Alcohol"},{"issue":"12","key":"10.1016\/j.jsat.2018.08.015_bb0090","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1111\/j.1530-0277.2008.00796.x","article-title":"Nondaily smoking and alcohol use, hazardous drinking, and alcohol diagnoses among young adults: Findings from the NESARC","volume":"32","author":"Harrison","year":"2008","journal-title":"Alcoholism: Clinical and Experimental Research"},{"issue":"9","key":"10.1016\/j.jsat.2018.08.015_bb0095","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.1360-0443.1991.tb01879.x","article-title":"The Fagerstr\u00f6m test for nicotine dependence: A revision of the Fagerstr\u00f6m Tolerance Questionnaire","volume":"86","author":"Heatherton","year":"1991","journal-title":"British Journal of Addiction"},{"issue":"3","key":"10.1016\/j.jsat.2018.08.015_bb0100","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1001\/archpsyc.1986.01800030107013","article-title":"Signs and symptoms of tobacco withdrawal","volume":"43","author":"Hughes","year":"1986","journal-title":"Archives of General Psychiatry"},{"issue":"24","key":"10.1016\/j.jsat.2018.08.015_bb0105","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1007\/s00213-014-3613-3","article-title":"Acute effects of low and high dose alcohol on smoking lapse behavior in a laboratory analogue task","volume":"231","author":"Kahler","year":"2014","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.jsat.2018.08.015_bb0110","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/ADM.0b013e31829623f4","article-title":"A double-blind, placebo-controlled trial assessing the efficacy of varenicline tartrate for alcohol dependence","volume":"7","author":"Litten","year":"2013","journal-title":"Journal of Addiction Medicine"},{"issue":"4","key":"10.1016\/j.jsat.2018.08.015_bb0115","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1046\/j.1471-4159.1997.68041511.x","article-title":"Presynaptic nicotinic modulation of dopamine release in the three ascending pathways studied by in vivo microdialysis: Comparison of naive and chronic nicotine-treated rats","volume":"68","author":"Marshall","year":"1997","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.jsat.2018.08.015_bb0120","first-page":"107","article-title":"Predictors of relapse in a bupropion trial for smoking cessation in recently-abstinent alcoholics: Preliminary results using an aggregate genetic risk score","volume":"6","author":"McGeary","year":"2012","journal-title":"Substance Abuse"},{"issue":"7","key":"10.1016\/j.jsat.2018.08.015_bb0125","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1001\/archinte.167.7.716","article-title":"Smoking status as a clinical indicator for alcohol misuse in US adults","volume":"167","author":"McKee","year":"2007","journal-title":"Archives of Internal Medicine"},{"issue":"2\u20133","key":"10.1016\/j.jsat.2018.08.015_bb0130","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.schres.2009.07.019","article-title":"Effects of the nicotinic receptor antagonist mecamylamine on ad-lib smoking behavior, topography, and nicotine levels in smokers with and without schizophrenia: A preliminary study","volume":"115","author":"McKee","year":"2009","journal-title":"Schizophrenia Research"},{"issue":"6","key":"10.1016\/j.jsat.2018.08.015_bb0135","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1001\/archinte.166.6.667","article-title":"A controlled trial of naltrexone augmentation of nicotine replacement therapy for smoking cessation","volume":"166","author":"O'Malley","year":"2006","journal-title":"Archives of Internal Medicine"},{"issue":"2","key":"10.1016\/j.jsat.2018.08.015_bb0140","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1001\/jamapsychiatry.2017.3544","article-title":"Effect of varenicline combined with medical management on alcohol use disorder with comorbid cigarette smoking: A randomized clinical trial","volume":"75","author":"O'Malley","year":"2018","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.jsat.2018.08.015_bb0145","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/add.13943","article-title":"Mecamylamine treatment for alcohol dependence: A randomized controlled trial","volume":"113","author":"Petrakis","year":"2017","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.jsat.2018.08.015_bb0150","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0091-3057(88)90438-8","article-title":"Mecamylamine reduces some EEG effects of nicotine chewing gum in humans","volume":"30","author":"Pickworth","year":"1988","journal-title":"Pharmacology, Biochemistry, and Behavior"},{"issue":"3\u20134","key":"10.1016\/j.jsat.2018.08.015_bb0155","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s00213-005-0250-x","article-title":"Nicotine and nonnicotine factors in cigarette addiction","volume":"184","author":"Rose","year":"2006","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.jsat.2018.08.015_bb0160","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1037\/1064-1297.6.3.331","article-title":"Nicotine-mecamylamine treatment for smoking cessation: The role of pre-cessation therapy","volume":"6","author":"Rose","year":"1998","journal-title":"Experimental and Clinical Psychopharmacology"},{"issue":"2","key":"10.1016\/j.jsat.2018.08.015_bb0165","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0091-3057(00)00465-2","article-title":"Acute effects of nicotine and mecamylamine on tobacco withdrawal symptoms, cigarette reward and ad lib smoking","volume":"68","author":"Rose","year":"2001","journal-title":"Pharmacology, Biochemistry, and Behavior"},{"issue":"1","key":"10.1016\/j.jsat.2018.08.015_bb0170","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/clpt.1994.105","article-title":"Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone","volume":"56","author":"Rose","year":"1994","journal-title":"Clinical Pharmacology & Therapeutics"},{"issue":"3\u20134","key":"10.1016\/j.jsat.2018.08.015_bb0175","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/(SICI)1098-2299(199607\/08)38:3\/4<243::AID-DDR13>3.0.CO;2-#","article-title":"Nicotine\/mecamylamine combination treatment for smoking cessation","volume":"38","author":"Rose","year":"1996","journal-title":"Drug Development Research"},{"issue":"1\u20132","key":"10.1016\/j.jsat.2018.08.015_bb0180","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0166-4328(00)00203-5","article-title":"Nicotinic mechanisms involved in the dopamine activating and reinforcing properties of ethanol","volume":"113","author":"Soderpalm","year":"2000","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.jsat.2018.08.015_bb0185","first-page":"239","article-title":"Clinical evaluation of mecamylamine for withdrawal from nicotine dependence","volume":"49","author":"Tennant","year":"1984","journal-title":"NIDA Research Monograph"},{"issue":"11","key":"10.1016\/j.jsat.2018.08.015_bb0190","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1111\/j.1360-0443.1991.tb01732.x","article-title":"The development and initial validation of a questionnaire on smoking urges","volume":"86","author":"Tiffany","year":"1991","journal-title":"British Journal of Addiction"},{"issue":"3","key":"10.1016\/j.jsat.2018.08.015_bb0195","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1530-0277.2002.tb02551.x","article-title":"Effects of combined systemic alcohol and central nicotine administration into ventral tegmental area on dopamine release in the nucleus accumbens","volume":"26","author":"Tizabi","year":"2002","journal-title":"Alcoholism: Clinical and Experimental Research"},{"issue":"3","key":"10.1016\/j.jsat.2018.08.015_bb0200","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1037\/a0025363","article-title":"Concurrent drinking and smoking among college students: An event-level analysis","volume":"26","author":"Witkiewitz","year":"2012","journal-title":"Psychology of Addictive Behaviors"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547218301326?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547218301326?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:48:42Z","timestamp":1760039322000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547218301326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":40,"alternative-id":["S0740547218301326"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2018.08.015","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tobacco use during a clinical trial of mecamylamine for alcohol dependence: Medication effects on smoking and associations with reductions in drinking","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2018.08.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}